Literature DB >> 29145734

Two dopaminergic genes, DRD4 and SLC6A3, are associated with body mass index in a Colombian sample of young adults.

Yeimy González-Giraldo1, Martha L Trujillo1, Diego A Forero1.   

Abstract

Obesity is becoming an epidemic in Latin American countries. Genetic analyses of endophenotypes for obesity, such as body mass index (BMI), are quite useful for research. In this study, we analysed two functional polymorphisms in the dopamine receptor 4 (DRD4) and dopamine transporter (SLC6A3) genes. A sample of 232 Colombian young subjects were recruited and evaluated for BMI. Two functional polymorphisms in the DRD4 and SLC6A3 and genes were genotyped by PCR and electrophoresis. A significant association was found between BMI and the polymorphisms in DRD4 and SLC6A3 genes. DRD4 4/4 genotype was associated with a lower mean BMI and SLC6A3 10/10 genotype was associated with a higher mean BMI. Our work provides additional novel findings about the association of dopaminergic genes with BMI in healthy young adults. In addition, our study is one the first analyses of candidate genes for BMI in Latin American samples.

Entities:  

Keywords:  Latin America; Molecular genetics; candidate genes; dopaminergic genes; obesity

Mesh:

Substances:

Year:  2017        PMID: 29145734     DOI: 10.1080/13813455.2017.1401643

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  3 in total

Review 1.  Brain on food: The neuroepigenetics of nutrition.

Authors:  Anoumid Vaziri; Monica Dus
Journal:  Neurochem Int       Date:  2021-06-13       Impact factor: 4.297

2.  Dopamine gene methylation patterns are associated with obesity markers and carbohydrate intake.

Authors:  Omar Ramos-Lopez; Jose I Riezu-Boj; Fermin I Milagro; J Alfredo Martinez
Journal:  Brain Behav       Date:  2018-07-11       Impact factor: 2.708

Review 3.  The Potential Effect of Rhizoma coptidis on Polycystic Ovary Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Liyun Duan; Xuedong An; Yuehong Zhang; Shenghui Zhao; Rongrong Zhou; Yingying Duan; Yuqing Zhang; Xinmin Liu; Fengmei Lian
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-08       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.